Researchers have developed a novel approach to remove pharmaceutical compounds from hospital wastewater using a fluidized aerobic bioreactor coupled with a tubesettler. This innovative system effectively eliminates a wide range of micropollutants, including antibiotics, anti-inflammatory drugs, and psychiatric medications, reducing the environmental impact of hospital waste. The study highlights the potential of this technology to address the growing concern over the presence of pharmaceutical residues in water bodies and its implications for public health and the ecosystem. Wastewater treatment and micropollutants are key topics explored in this research.
Tackling the Challenge of Pharmaceutical Pollution in Hospital Wastewater
Hospitals generate a significant amount of wastewater containing a diverse array of pharmaceutical compounds, posing a serious threat to the environment. These micropollutants, present in concentrations ranging from nanograms to micrograms per liter, can have detrimental effects on aquatic ecosystems and human health. Conventional wastewater treatment plants often struggle to effectively remove these trace contaminants, necessitating the development of innovative solutions.
A Fluidized Aerobic Bioreactor Approach
A team of researchers has devised a novel treatment system that combines a fluidized aerobic bioreactor (FAB) with a tubesettler to address this challenge. The FAB system utilizes the power of microorganisms to break down and remove a wide range of pharmaceutical compounds, including antibiotics, anti-inflammatory drugs, and psychiatric medications, from hospital wastewater.
Efficient Removal of Micropollutants
The study found that the FAB system was highly effective in removing various micropollutants. For example, the removal efficiency for the antibiotic sulfamethoxazole and the anti-inflammatory drug ketoprofen was 54% and 77%, respectively. Even compounds like the antiepileptic drug carbamazepine and the psychiatric medication lorazepam were eliminated at 64% and 32%, respectively.
Tubesettler: A Polishing Unit for Enhanced Performance
The researchers also integrated a tubesettler as a polishing unit, which further improved the overall removal efficiency of the system. The tubesettler was found to be a suitable alternative to a secondary clarifier, providing an additional 15-43% removal of the targeted pharmaceutical compounds.
Addressing Environmental Risks
The study not only focused on the removal of micropollutants but also assessed the environmental risk posed by the treated wastewater. The researchers calculated the hazard quotient (HQ), a measure of the potential risk to aquatic ecosystems. The results showed that the treated effluent from the FAB system and the tubesettler posed a negligible risk, with HQ values below 0.5, indicating a safe level for the environment.
Implications and Future Directions
This innovative treatment approach has the potential to significantly mitigate the environmental impact of hospital wastewater, reducing the release of pharmaceutical residues into water bodies. The researchers suggest that further studies are needed to explore the integration of additional treatment processes, such as disinfection and hybrid systems, to enhance the overall performance of the FAB reactor.
In conclusion, the development of the fluidized aerobic bioreactor coupled with a tubesettler represents a promising solution for the sustainable treatment of hospital wastewater, addressing the pressing issue of pharmaceutical pollution and its ecological implications.
Author credit: This article is based on research by Meshel Qablan Alkahtani, Rachida El Morabet, Roohul Abad Khan, Amadur Rahman Khan.
For More Related Articles Click Here
